Skip to main content
. 2022 Aug 30;11(9):1721. doi: 10.3390/antiox11091721

Table 4.

Effect of diosmin and/ or trolox on TLC and DLC of CFA-induced arthritic animals.

Groups TLC
(Cell × 103/mm3)
% Change Neutrophil % Change Lymphocyte % Change Monocyte % Change Eosinophil % Change
Normal 5.78 ±
0.26 a
- 1274.3 ± 32.50 a - 2991.0 ± 147.4 a - 117 ±
12.3 a
- 53.7 ±
3.7 a
-
Arthritic 11.4 ±
0.49 c
98 3266.3 ± 247.9 c 156 7865.8 ± 354.3 c 163 289 ±
24.4 c
147 116.8 ±
7.3 c
117.5
Arthritic treated with Diosmin 8.88 ±
0.28 b
−22 2272.3 ± 137.4 b −30.4 5793.7 ± 226.8 b −26.3 227.7 ±
9.6 b
−21.2 88.7 ±
2.8 b
−24.1
Arthritic treated with Trolox 8.60 ±
0.66 b
−25 2161.2 ± 204.6 b −33.8 5588 ±
260.9 b
−30 130 ±
15.1 a
−55 88.3 ±
5.1 b
−24.4
Arthritic treated with Diosmin and Trolox 9.12 ±
0.24 b
−20 2958.2 ± 70.00 c −9.4 5440 ±
322.6 b
−30.8 125.2 ± 26.9 a −56.7 94.8 ±
6.1 b
−18.8

Data are expressed as mean ± standard error. Each group has a total of six individuals. In the same column, means with the same superscript symbol(s) are not statistically significant. Comparisons of the arthritic group with the normal and arthritic treatment groups with the arthritic group yielded percentage changes (% change).